Xoma

XOMA Royalty Corp. aggregates biotech royalties across the U.S. and Asia Pacific, owning economic rights to early‑to‑mid‑stage therapeutic assets with future milestone and royalty upside. The company partners with Novartis, Takeda and others.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Financial Services
Industry: Investment Management

Employees: 13
HQ: EmeryVille

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
XOMA	Xoma Cap: 0.4B \| P/E: 39.8	EQUITY	NMS	USD	US98419J2069	Active	📈